Angela van der Salm
Director
DADA Consultancy B.V.
Netherlands
Biography
Pharmacovigilance specialist with a PhD on hormonal regulation in an animal model and several years of experience in the generic and innovator industry. Manages pharmacovigilance systems for different clients and acts as QPPV for a number of them, creates safety data exchange agreements, ensures quality control and reporting compliance. Author of numerous scientific publications and safety reports on a variety of drugs and indications. Interested in the training of personnel, compliance monitoring, regulatory drug safety and quality assurance from clinical development for investigational to post-authorisation vigilance for (non-)marketed products. Proactive teamplayer with a high problem-solving capacity and good intersocial skills, cross-departmental expertise towards regulatory and clinical and non-clinical services. Management Team member of DADA, mother of two boys (happily married to their dad) and broadly interested in science and nature. Angela specialises in providing tailor made pharmacovigilance support, including QPPV provision and responsibility for the clients pharmacovigilance systems. Create safety data exchange agreements on behalf of our clients, database management of patient reports on adverse events related to medicinal product use, give training on basic and advanced pharmacovigilance, write periodic reports on the risk-benefit balance of pharmaceutical products by evaluating literature, case reports and all other relevant sources. Monitor the department for quality and compliance.
Research Interest
Benefit/Risk evaluation and management, Off label use and Medication errors